Sign In
Buy CDNA
$22.31
+0.240 (+1.09%)
At Close: Jun 03, 2026
CareDx, Inc.'s (CDNA) CEO Reginald Seeto on Q1 2021 Results - Earnings Call Transcript
09:08pm, Wednesday, 05'th May 2021
CareDx, Inc.'s (CDNA) CEO Reginald Seeto on Q1 2021 Results - Earnings Call Transcript
CareDx (CDNA) Q1 Earnings and Revenues Surpass Estimates
07:56pm, Wednesday, 05'th May 2021
CareDx (CDNA) delivered earnings and revenue surprises of 1500.00% and 10.91%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
ARK Genomic Revolution ETF: Value Realization Will Take Time
04:46am, Monday, 03'rd May 2021
ARK Genomic Revolution ETF: Value Realization Will Take Time
CareDx to Present New Heart Transplant Data at the International Society for Heart and Lung Transplantation Annual Meeting
07:00am, Friday, 23'rd Apr 2021
Renowned transplant clinicians to present 15 heart abstracts at ISHLT Renowned transplant clinicians to present 15 heart abstracts at ISHLT
Palmetto MolDx Issues Foundational Coverage for Molecular Testing in Solid Organ Allograft Rejection
11:38am, Thursday, 22'nd Apr 2021
Current Medicare coverage for CareDx services remains unchanged under the new universal coverage policy Current Medicare coverage for CareDx services remains unchanged under the new universal coverage
Leading transplant clinicians to present data in seven abstracts at International Society of Heart and Lung Transplantation Annual Meeting Leading transplant clinicians to present data in seven abstra
CareDx to Report First Quarter 2021 Financial Results
04:00pm, Wednesday, 21'st Apr 2021
SOUTH SAN FRANCISCO, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clini
CareDx Showcases Transplantation Innovation and Leadership in Europe at EFI 2021
07:00am, Tuesday, 20'th Apr 2021
Virtual Events to Highlight New Data and AlloSeq Solutions for European Labs and Clinicians Virtual Events to Highlight New Data and AlloSeq Solutions for European Labs and Clinicians
CareDx to Present at UNOS Transplant Management Forum
07:00am, Friday, 16'th Apr 2021
Company to showcase its latest integrated solutions for improving care across the whole transplant journey Company to showcase its latest integrated solutions for improving care across the whole trans
CareDx Announces New HLA Typing Service Offering for Research Purposes
07:00am, Thursday, 08'th Apr 2021
Initial projects underway for global pharmaceutical company Initial projects underway for global pharmaceutical company
CareDx to Participate in National Kidney Foundation 2021 Spring Clinical Meetings
07:00am, Monday, 05'th Apr 2021
CareDx to Host Virtual Exhibitor Showcase and Continuing Medical Education Program CareDx to Host Virtual Exhibitor Showcase and Continuing Medical Education Program
CareDx Enhances Leadership Team with Key Appointments
07:00am, Wednesday, 31'st Mar 2021
CareDx Builds for the Future by Investing in Talent CareDx Builds for the Future by Investing in Talent
CareDx Names Ankur Dhingra as New Chief Financial Officer
04:05pm, Thursday, 11'th Mar 2021
SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clini
Like Guardant Health? You'll Love CareDx
08:17am, Wednesday, 03'rd Mar 2021
This under-the-radar diagnostics company is thriving yet reasonably priced.
CareDx, Inc. (CDNA) CEO Reginald Seeto on Q4 2020 Results - Earnings Call Transcript
10:38pm, Wednesday, 24'th Feb 2021
CareDx, Inc. (CDNA) CEO Reginald Seeto on Q4 2020 Results - Earnings Call Transcript
